Although reported incidence rates have increased in the past 20 years,<unk>  is still a relatively rare cancer. The incidence rate varies from one country to another, from a low rate of less than 1 per 1,000,000 in Tunisia and Morocco, to the highest rate in Britain, Australia and Belgium: 30 per 1,000,000 per year. For comparison, populations with high levels of smoking can have a lung cancer incidence of over 1,000 per 1,000,000. Incidence of malignant<unk>  currently ranges from about 7 to 40 per 1,000,000 in industrialized Western nations, depending on the amount of asbestos exposure of the populations during the past several decades. Worldwide incidence is estimated at 1-6 per 1,000,000. Incidence of<unk>  lags behind that of asbestosis due to the longer time it takes to develop; due to the cessation of asbestos use in developed countries,<unk>  incidence is expected to decrease. Incidence is expected to continue increasing in developing countries due to continuing use of asbestos.<unk>  occurs more often in men than in women and risk increases with age, but this disease can appear in either men or women at any age. Approximately one fifth to one third of all<unk> s are peritoneal. Less than 5% of<unk> s are pericardial. The prevalence of pericardial<unk>  is less than 0.002%; it is more common in men than women. It typically occurs in a person's 50s-70s. Between 1940 and 1979, approximately 27.5 million people were occupationally exposed to asbestos in the United States. Between 1973 and 1984, the incidence of pleural<unk>  among Caucasian males increased 300%. From 1980 to the late 1990s, the death rate from<unk>  in the USA increased from 2,000 per year to 3,000, with men four times more likely to acquire it than women. More than 80% of<unk> s are caused by asbestos exposure. The incidence of peritoneal<unk>  is 0.5–3.0 per million per year in men, and 0.2–2.0 per million per year in women. UK<unk>  accounts for less than 1% of all cancers diagnosed in the UK, (around 2,600 people were diagnosed with the disease in 2011), and it is the seventeenth most common cause of cancer death (around 2,400 people died in 2012).
Mesothelioma
Hemangioendothelioma
Epithelioid hemangioendothelioma
Pulmonary sclerosing pneumocytoma
Large-cell lung carcinoma
Giant-cell carcinoma of the lung
Sarcomatoid carcinoma of the lung
Sarcoma